Prenatal diagnosis and treatment of congenital adrenal hyperplasia

Pediatric Endocrinology Reviews

Volumn 4, Issue 2, 2006, Pages 99-105

  Nimkarn, Saroj ^a   New, Maria I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

21 Hydroxylase deficiency; Congenital adrenal hyperplasia; Prenatal diagnosis; Prenatal treatment; Steroid hydroxylases

Indexed keywords

17 OXOSTEROID; ANDROGEN; DEXAMETHASONE; HYDROCORTISONE;

ANDROGEN SYNTHESIS; CONGENITAL ADRENAL HYPERPLASIA; DRUG DOSE REDUCTION; DRUG TOLERABILITY; ENZYME ACTIVITY; GENETIC ANALYSIS; GENOTYPE; HUMAN; LONG TERM CARE; MOLECULAR GENETICS; PRENATAL DIAGNOSIS; REVIEW; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS;

ADRENAL HYPERPLASIA, CONGENITAL; HUMANS; INFANT, NEWBORN; PRENATAL DIAGNOSIS;

EID: 33847715958     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. New M. Prenatal treatment of congenital adrenal hyperplasia. The United States experience. Endocrinol Metab Clin North Am 2001;30:1-13
2. New MI, White PC. Genetic disorders of steroid metabolism. In: Thakker RV, editor. Genetic and molecular biological aspects of endocrine disease. London Bailliere Tindall 1995;525-554
3. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-874
4. Zerah M, Ueshiba H, Wood E, Speiser PW, Crawford C, McDonald T, Pareira J, Gruen D, New MI. Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. J Clin Endocrinol Metab 1990;70:1662-1667
5. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985;37:650-667
6. Sherman SL, Aston CE, Morton NE, Speiser PW, New MI. A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. Am J Hum Genet 1988;42:830-838
7. New MI, Wilson RC. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci USA 1999;96:12790-12797
8. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788
9. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy D, Pang S, Levine L. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983;57:320-326
10. Pang S, Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993;2:105-139
11. White PC, New MI, Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986;83:5111-5115
12. White P, Vitek A, Dupont B, New M. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. In: Proc Nat Acad Sci USA 1998;4436-4440
13. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003;21:577-581
14. White P, Speiser P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291
15. Lee HH, Lee YJ, Chan P, Lin CY. Use of PCR-based amplification analysis as a substitute for the southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia. Clin Chem 2004;50:1074-1076
16. Nimkarn S, Weerakulwattana L, Chaichanwatanakul K. Comprehensive study of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in 92 Thai patients. In: 11th Asian Congress of Pediatrics; 2003 November 2-7; Bangkok, Thailand 11th Asian Congress of Pediatrics 2003.pp.80
17. Tukel T, Uyguner O, Wei JQ, Yuksel-Apak M, Saka N, Song DX, et al. A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2003;88:5893-5897
18. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995;80:2322-2329
19. Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans. Proc Natl Acad Sci USA 1988;85:7486-7490
20. Amor M, Parker KL, Globerman H, New MI, White PC. Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1988;85:1600-1607
21. Tusie-Luna M, Traktman P, White PC. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. Journal of Biological Chemistry 1990;265:20916-20922
22. New M, Carlson A, Obeid J, Marshall I, Cabrera M, Goseco A, Lin-Su K, Putnam A, Wei J, Wilson R. Update: Prenatal diagnosis for congenital adrenal hyperplasia in 595 pregnancies. The Endocrinologist 2003;13:233-239
23. New M, Carlson A, Obeid J, Marshall I, Cabrera M, Goseco A, Lin-Su K, Putnam A, Wei J, Wilson R. Extensive Personal Experience: Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001;86:5651-5657
24. Krone N, Braun A, Roscher A, Knorr D, Schwarz H. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000;85:1059-1065
25. Dolzan V, Solyom J, Fekete G, Kovacs J, Rakosnikova V, Votava F, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 2005;153:99-106
26. Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 2003;88:3852-3859
27. Jeffcoate T, Fleigner J, Russell S, Davis J, Wade A. Diagnosis of the adrenogenital syndrome before birth. Lancet 1965;2:553
28. Marshall I, New M. Pediatric Endocrinology: Adrenal Disorders. In: De Groot L, editor. Endotext; 2006. www.endotext.org. Accessed 18 Sept 06
29. Simpson J. Diagnostic Procedure for Prenatal Genetic Diagnosis. In: Gabbe S, Niebyl J, Simpson J, editors. Gabbe: Obstetrics - Normal and Problem Pregnancies. 4th ed. Orlando WB Saunders Company 2002.pp. 200-204
30. American College of Obstetricians and Gynecologists Committee on Genetics Committee Opinion: Chorionic villus sampling. Int J Gynaecol Obstet 1996;52:206-208
31. Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 1995;80:1635-1640
32. Mao R, Nelson L, Kates R, Miller CE, Donaldson DL, Tang W, Ward K. Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions. Prenat Diagn 2002;22:1171-1176
33. Day DJ, Speiser PW, Schulze E, Bettendorf M, Fitness J, Barany F, White PC. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 1996;5:2039-2048
34. Section on Endocrinology and Committee on Genetics. Technical Report: congenital adrenal hyperplasia. Pediatrics 2000;106:1511-1518
35. Rijnders RJ, van der Schoot CE, Bossers B, de Vroede MA, Christiaens GC. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98:374-378
36. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002;346:1502
37. Fiorentino F, Biricik A, Nuccitelli A, De Palma R, Kahraman S, Iacobelli M, et al. Strategies and clinical outcome of 250 cycles of Preimplantation Genetic Diagnosis for single gene disorders. Hum Reprod 2006;21:670-684
38. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984;105:799-803
39. Goto M, Piper Hanley K, Marcos J, Wood PJ, Wright S, Postle AD, et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 2006;116:953-960
40. Forest M. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Reproduction Update 2004;10:469-485
41. Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI. Extensive personal experience: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1995;80:2014-2020
42. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002;58:188-195
43. Forest M, Morel Y, David M. Prenatal Treatment of Congenital Adrenal Hyperplasia. Trends in Endo Metab 1998;9:284-289
44. Lajic S, Wedell A, Bui T, Ritzen E, Holst M. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872-3880
45. Forest MG, Dorr HG. Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Retrospective follow-up study of 253 treated pregnancies in 215 families. Endocrinologist 2003;13:252-259
46. Trautman PD, Meyer-Bahlburg HFL, Postelnek J, New MI. Mothers' reactions to prenatal diagnostic procedures and dexamethasone treatment of CAH. J Psycho Obst Gyn 1996;17:175-181
47. Lajic S, Nordenstrom A, Ritzen EM, Wedell A. Prenatal treatment of congenital adrenal hyperplasia. Eur J Endocrinol 2004;151:U63-U69
48. Koops BL, Morgan LJ, Battaglia FC. Neonatal mortality risk in relation to birth weight and gestational age: update. J Pediatr 1982;101:969-977
49. Pang SY, Pollack MS, Marshall RN, Immken L. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1990;322:111-115
50. New M. Prenatal treatment of congenital adrenal hyperplasia: authors differ with technical report. Pediatrics 2001;107:804
51. Trautman PD, Meyer-Bahlburg HF, Postelnek J, New MI. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 1995;20:439-449
52. Hall C, Jones J, Meyer-Bahlburg H, Dolezal C, Coleman M, Foster P, Price D, Clayton P. Behavioral and physical masculinization are related to genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004;89:419-424
53. Meyer-Bahlburg H, Dolezal C, Baker S, Carlson A, Obeid J, New M. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J Clin Endocrinol Metab 2004;89:610-614
54. Meyer-Bahlburg H, Dolezal C, Baker S, Carlson A, Obeid J, Vogiatzi M, New M. Diminished behavioral masculinization in girls with congenital adrenal hyperplasia after prenatal dexamethasone exposure. Hormones and Behavior 2003;44:64
55. Meyer-Bahlburg H, Dolezal C, Haggerty R, Baker S, Enfield L, Sihler B, Carlson A, Obeid J, New M. Performance on cognitive tests in children with a history of prenatal dexamethasone exposure. Pediatric Research 2001;49:58A